Trial Profile
Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2014
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jul 2014 New trial record